Pharmaceutical Business review

Wyeth to invest $280 million in China nutritional plant

The new facility will primarily produce infant formula milk powder and other nutritional products. The new facility will become part of Wyeth’s global nutritional manufacturing and supply network and will feature state-of-the-art technology for manufacturing milk powder for infants and young children.

Construction at the site has started, and the plant is scheduled to be operational by late 2010. At full operation, the plant is expected to employ about 500 employees. Products made at this facility will primarily supply the local market.